Morgan Stanley’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.42M | Sell |
|
|||||
|
2025
Q1 | $2.88M | Buy |
|
|||||
|
2024
Q4 | $2.75M | Buy |
|
|||||
|
2024
Q3 | $1.53M | Buy |
|
|||||
|
2024
Q2 | $1.63M | Buy |
|
|||||
|
2024
Q1 | $1.77M | Sell |
|
|||||
|
2023
Q4 | $4.3M | Buy |
|
|||||
|
2023
Q3 | $2.67M | Sell |
|
|||||
|
2023
Q2 | $7.64M | Buy |
|
|||||
|
2023
Q1 | $6.86M | Buy |
|
|||||
|
2022
Q4 | $6.44M | Sell |
|
|||||
|
2022
Q3 | $6.95M | Buy |
|
|||||
|
2022
Q2 | $5.1M | Buy |
|
|||||
|
2022
Q1 | $3.83M | Sell |
|
|||||
|
2021
Q4 | $7.17M | Sell |
|
|||||
|
2021
Q3 | $14.8M | Buy |
|
|||||
|
2021
Q2 | $12.6M | Buy |
|
|||||
|
2021
Q1 | $2.46M | Buy |
|
|||||
|
2020
Q4 | $118K | Buy |
|